Financial News

Financial Report: Johnson & Johnson

Pharmaceutical sales up 4% in the quarter and for the year

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Johnson & Johnson 4Q Revenues: $20.7 billion (+2%) 4Q Earnings: 4.0 billion (+32%) FY Revenues: $82.1 billion (+1%) FY Earnings: $15.1 billion (-1%) Comments: Pharmaceutical sales were $10.5 billion in the quarter, up 4%. For the year pharmaceutical sales were $42.2 billion, up 4%. Growth for the year was driven by STELARA for the treatment of immune-mediated inflammatory diseases, DARZALEX for the treatment of multiple myeloma, IMBRUVICA for treating certain B-cell malig...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters